Brixy Pharmaceuticals Private Limited
About Brixy Pharmaceuticals Private Limited
Data last updated:
Brixy Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the basic chemicals except fertilizers and nitrogen compounds segment of the chemicals sector. It was incorporated on 09 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2018PTC121728. Its GSTIN is 36AAHCB6050B1Z3 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lavanya Kondabathula and Sridhar Kondabathula.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2019, the company reported a revenue of ₹30.72 Lakh. For the same year it recorded a net profit of ₹28,636 (net margin 0.9%) and EBITDA of ₹93,822 (EBITDA margin 3.1%).
The company is associated with 1 brand: Brixy Pharmaceuticals.
Company details
Contact details
Brixy Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No:6 Padmaja Colony Kakaguda Trimulgherry Near Goutham Juniour Collage Secundera, Bad, Hyderabad, Telangana, India – 500015
- IndustryChemicals, Basic Chemicals Except Fertilizers And Nitrogen Compounds, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Brixy Pharmaceuticals operates one associated brand: Brixy Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of generic drugs | brixypharma.com |
Business activity
The main business activity of Brixy Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Brixy Pharmaceuticals Private Limited, buy the company report.
Financials of Brixy Pharmaceuticals Private Limited
FY 2019 filings availableBrixy Pharmaceuticals Private Limited reported revenue of ₹30.72 Lakh for FY 2019.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹93,822 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹28,636 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.1% | |
| Net Profit Margin | 0.9% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Brixy Pharmaceuticals Private Limited, buy the company report.
Board of directors of Brixy Pharmaceuticals Private Limited
Brixy Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lavanya Kondabathula | Director | 09 Jan 2018 | 8 Years 10 Months | Current |
| Sridhar Kondabathula | Director | 09 Jan 2018 | 8 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Brixy Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brixy Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Brixy Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCB6050B1Z3 | Telangana | Active | 03 May 2018 |
To see the full GST registrations and return filing status of Brixy Pharmaceuticals Private Limited, buy the company report.
Recent activity
Brixy Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Lavanya Kondabathula was appointed as Director on 09 Jan 2018.
Frequently asked questions
Brixy Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in basic chemicals except fertilizers and nitrogen compounds, within the chemicals industry. It was incorporated on 09 January 2018 (8+ years old) and is registered under CIN U24110TG2018PTC121728.
Brixy Pharmaceuticals has 2 current directors:
- Lavanya Kondabathula - Director
- Sridhar Kondabathula - Director
The latest financial statements of Brixy Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Brixy Pharmaceuticals is 36AAHCB6050B1Z3, registered in Telangana.
The CIN (Corporate Identification Number) of Brixy Pharmaceuticals is U24110TG2018PTC121728. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brixy Pharmaceuticals was incorporated on 09 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Lavanya Kondabathula was appointed as Director on 09 Jan 2018. Sridhar Kondabathula was appointed as Director on 09 Jan 2018.
The registered office of Brixy Pharmaceuticals is at Plot No:6 Padmaja Colony Kakaguda Trimulgherry Near Goutham Juniour Collage Secundera, Bad, Hyderabad, Telangana, India – 500015.
Brixy Pharmaceuticals operates in the chemicals industry, in the basic chemicals except fertilizers and nitrogen compounds segment.
Brixy Pharmaceuticals has 1 associated brand: Brixy Pharmaceuticals.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
